and did you know that on these "soft rollouts", the company needs to supply the product to the merchant at NO COST to the merchant? Only if and when the products sell does the supplier get paid. You're going to be very disappointed at Q1 Q2 numbers when they come in. Q1 is just one month after Q4-2018 results are due, May 15-ish.
Impressive JGD!!! Anyone following Biel realizes that momentum has completely switched into Biel's favor. The world has finally figured out that it needs a drug free approach to pain. While Actipatch has always been a great product, consumers had no reason to buy it...until recently that is. We've been content to gobble down pills to cope with pain for far too long. Luckily for Actipatch, pain killing pills are being vilified these days. Watch for Actipatch momentum to pickup speed. Go Biel$$$
News 
Market Data 
Discover 
